active substance:1 tablet contains vasomotion (vasomotion hydrochloride) 10 mgother ingredients:potato starch, cellulose microcrystalline, lactose, povidone, magnesium stearate.The
Tablets are white or creamy-white, flat cylindrical shape with a chamfer.The
305022, Russian Federation, G.. Kursk, street the Second Aggregate, 1A/18.The
Anksiolitiki. ATC code N05B X.
Afobazol- derived 2-mercaptobenzimidazole, selective anxiolytic, not belonging to the class of benzodiazepine receptor agonists. Prevents the development of membrane-dependent changes in the GABA receptor.
the Drug has an anksioliticheskim action with an activating component, not accompanied by hypnosedative effects (sedative effect is manifested in doses, 40-50 times higher ED50for anksioliticheskogo action). The drug has no muscle relaxant properties, negative impact on memory and attention. When it is used, drug dependence is not formed and the withdrawal syndrome does not develop.
the action of the drug is implemented mainly in the form of a combination of anxiolytic (eliminates anxiety) and stimulating (activating) effects. Reduce or eliminate anxiety (concern, foreboding, fear, irritability), tension (fearfulness, tearfulness, anxiety, inability to relax, insomnia, fear), and, consequently, somatic (muscular, sensory, cardiovascular, respiratory, gastrointestinal symptoms), vegetative (dry mouth, sweating, dizziness), cognitive (difficulty concentrating, poor memory) violations observed at 5-7 days of treatment. The maximum effect is achieved by the end of 4 weeks of treatment and remains after discontinuation of the drug, an average of 1-2 weeks. The application of the drug to asthenic individuals in the event of anxiety, uncertainty, increased vulnerability and emotional lability, a tendency to emotional and stress reactions is especially shown.
anxiety: generalized anxiety disorder, neurasthenia, adjustment disorder in patients with dermatological, cancer, somatic (bronchial asthma, irritable bowel syndrome, systemic lupus erythematosus, ischemic heart disease, arterial hypertension, arrhythmias) diseases.
as part of the complex treatment of sleep disorders associated with anxiety, neurocirculatory dystonia, premenstrual syndrome, alcohol withdrawal syndrome, to ease the condition of the syndrome Smoking cessation.
hypersensitivity to the components of the drug.
the Drug contains lactose, so patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should not use the drug.
during pregnancy and lactation, do not take this medicine.The
No studies have been carried out to study the impact on the ability to drive vehicles or operate machinery.The
the use of the drug for children is contraindicated.
Used by adults inside after eating.
Usually used on 1 tablet 3 times a day. The maximum daily dose is 60 mg.
The duration of treatment is 2-4 weeks. According to the doctor's prescription, the treatment can be increased to 3 months.
with a significant overdose, it is possible to develop a sedative effect and increased drowsiness without manifestations of muscle relaxation. As an emergency aid caffeine sodium benzoate is used 20% solution of 1 ml 2-3 times a day subcutaneously.
possible allergic reactions (including itching, urticaria, sneezing, rhinitis, dermatitis, vasculitis), headache.
afobazoledoes not affect the narcotic effect of ethanol and the hypnotic effect of thiopental. Potentiates the anticonvulsant effect of carbamazepine.
Causes increased anxiolytic action of diazepam.The
2 years old.
Do not use after the expiry date indicated on the package.
keep out of reach of children In the original packaging at temperatures not exceeding 25 ° C.The
Tablets No. 20 in blister. 3 blisters in a pack of cardboard.The
over the counter.
afobazole differs from other similar products in the duality of the effects on the human body. It has both calming and stimulating effect, due to which it is actively used in the treatment of anxiety, neuroses and post-traumatic stress disorders. Afobazole also has a protective effect on the cells of the nervous system, contributing to the increase of their bioenergy potential.
afobazole is taken orally immediately after a meal. Single dose of 10 mg, the Optimal daily dose must be determined by the physician based on the diagnosis and course of the disease. As a rule, the improvement of the patient's condition in the treatment of Afobazol occurs after 5-6 days, however, the minimum course of treatment is at least two weeks.